OMX30 1 580 -0,1%  OMXH25 3 773 -0,4%  OMXC20 904 0,0%  Dow 20 597 -0,3%  Nas 5 364 0,2%  EUR 9,5184 0,0%  USD 8,8119 -0,2%  Olja 51,0 0,9%  Guld 1 246 0,1% 

STRATEC Biomedical Aktie

55,16EUR -0,09EUR -0,16%
<
Bolag
Terminer
Profil
>
<
Relaterade värdepapper
ETP:er
Obligationer
>

Fundamentala nyckeltal för STRATEC Biomedical

2016 2017e 2018e 2019e 2020e
Utdelning 0,77 0,84 0,96 1,22 -
Direktavkastning (i %) 1,70 1,79 2,05 2,60 2,38
PE-tal 21,97 19,16 16,66 13,98 13,99
Resultat/aktie 2,06 2,44 2,80 3,34 -

Nyheter om STRATEC Biomedical AG

Inga nyheter tillgängliga
ytterligare nyheter

Analyser om STRATEC Biomedical AG

Mar, 16 2017 STRATEC Biomedical Buy Oddo Seydler Bank AG
Mar, 15 2017 STRATEC Biomedical Hold HSBC
Mar, 14 2017 STRATEC Biomedical Buy Warburg Research
Mar, 14 2017 STRATEC Biomedical Buy Warburg Research
Jan, 25 2017 STRATEC Biomedical Buy Warburg Research
ytterligare analyser

STRATEC Biomedical Peer Group

Agilent Technologies 53,08
-0,2%
Baxter International 52,03
0,7%
Becton, Dickinson & 183,89
0,1%
Carl Zeiss Meditec 38,94
0,0%
Drägerwerk vz 93,09
0,1%
Fresenius Medical Care 77,61
0,2%
Gerresheimer 72,52
-0,7%
Pulsion Medical Systems 24,25
0,0%
STRATEC Biomedical 55,16
-0,2%
Smith & Nephew 12,43
-0,7%
bioMerieux SA 154,65
0,1%
pagehit

Lägg till instrument

Vad tycker du?

Profil STRATEC Biomedical AG

till bolagsprofilen
STRATEC Biomedical AG designs and manufactures fully automated analyzer systems for its partners in the fields of clinical diagnostics and biotechnology. These partners market such systems, in general together with their own reagents, as system solutions to laboratories, blood banks and research institutes around the world. The company develops its products on the basis of its own patented technologies. The company operates through its segments: Instrumentation and All other segments. The Instrumentation segment designs and manufactures fully automated analyzer systems for its clinical diagnostics and biotechnology customers. The All other segments develop workflow software for networking several analyzer systems and develops and sells scientific materials and technologies such as nucleic acid purification. STRATEC Biomedical was founded by Hermann Leistner in 1979 and is headquartered in Birkenfeld, Germany.

Realtidskurs STRATEC Biomedical AG

Bid
55,31
EUR
Ask
55,80
EUR
Kurstid
17:15
Börsen STU

Aktiekurs STRATEC Biomedical AG i EURPUSH CHART

Kurs 55,16 EUR -0,09 -0,16 %
Kurstid 17:36:15
Datum 24.03.2017
Öppning 54,95
Gårdagen 55,25
Dagshögsta 56,23
Dagslägsta 54,95
52 v. högsta 58,50
52 v. lägsta 41,30
52 v. perf.
Volym (Antal) 12 277
Börsvärde (SEK) 6,22 Mrd
Börsen
Kurs för 55,16 EUR från börsen XETRA motsvarar med aktuell växelkurssentspricht EUR/SEK en kurs på 525,03 SEK.

Till aktien STRATEC Biomedical

Ticker
ISIN DE000STRA555
Index Prime All Share, CDAX, Technology All Share, BX Swiss - EMEA

STRATEC Biomedical Nyckeltal

Börsvärde i SEK 6,22 Mrd
Free float % 39,77
Antal aktier mio. 11,86
Cashflow/aktie i lokal valuta 2,84
Bokvärde/aktie i lokal valuta 11,78
60 dagar vola 34,89
PBV 3,85

STRATEC Biomedical Historiska kurser

2017-03-23 55,25 6 829
2017-03-22 54,95 16 207
2017-03-21 54,57 16 603
2017-03-20 54,00 30 089
2017-03-17 52,32 91 898

Aktier i samma industri med bättre 1 års perf.

m-u-t AG Meßgeräte für Medizin- und Umwelttechnik 55,6 %
CyBio AG 54,6 %
Sartorius AG Vz. 44,2 %

Riktkurser för STRATEC Biomedical

Sell
Hold
Buy
50
55
60
65
70